Springer New York
Glycerophospholipids in the Brain: Phospholipases A2 in Neurological Disorders
Glycerophospholipids in the Brain: Phospholipases A2 in Neurological Disorders
Couldn't load pickup availability
Glycerophospholipids in Brain: Phospholipases A[subscript 2] in Neurological Disorders comprehensively describes: metabolism in brain of glycerophospholipids, including those containing a vinyl ether group (plasmalogens), cutting-edge information on the properties and roles of phospholipases A[subscript 2] in the central nervous system, release by phospholipases A[subscript 2] of second messengers (arachidonic acid, docosahexaenoic acid, and lysophospholipid) from neural membrane phospholipids and their neurochemical effects on brain metabolism and function, involvement of phospholipases A[subscript 2] in neurological and neuropsychiatric disorders, and the use of phospholipase A[subscript 2] inhibitors for the treatment of diseases associated with altered phospholipid metabolism, methods for the assays of phospholipases A[subscript 2] and their clinical significance.
This unique volume will be invaluable not only to those interested in biochemical properties of phospholipases A[subscript 2], but also their involvement in neurological disorders. Students will benefit from it as a supplement for a range of neuroscience courses. Clinicians will find it invaluable as well for understanding molecular aspects of neurodegeneration in acute neural trauma (stroke) andneurodegenerative diseases (Alzheimer disease) that are mediated by phospholipases A[subscript 2].
The information in Glycerophospholipids in Brain: Phospholipases A[subscript 2] in Neurological Disorders is presented in a lively manner that has never been attempted until now in this specialized format. It will be the essential text for the authoritative in the field.
Share
